[go: up one dir, main page]

Solini et al., 2005 - Google Patents

Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases

Solini et al., 2005

View HTML
Document ID
11426980906665496765
Author
Solini A
Iacobini C
Ricci C
Chiozzi P
Amadio L
Pricci F
Di Mario U
Di Virgilio F
Pugliese G
Publication year
Publication venue
Kidney international

External Links

Snippet

Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases. Background Extracellular adenosine triphosphate (ATP)(eATP) mediates several biologic activities via purinergic P2 receptors (P2Rs). This study aimed at …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Solini et al. Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases
Reed et al. Mast cell tryptase and proteinase‐activated receptor 2 induce hyperexcitability of guinea‐pig submucosal neurons
Doyle et al. TGFβ signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke
Pisconti et al. RETRACTED: Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion
Maier et al. Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration
Orellana et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels
Ward et al. Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor
Guttmann et al. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ
Waetzig et al. MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling
Horgan et al. Examining the mechanism of Erk nuclear translocation using green fluorescent protein
Veit et al. Anoctamin-6 regulates ADAM sheddase function
Boswell et al. Essential role of BMPs in FGF-induced secondary lens fiber differentiation
Roscioni et al. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells
Yang et al. 1, 25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells
JP2010500567A (en) Control of bone formation by inhibition of bone formation inhibitory factor
Nakatsuka et al. Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P
Dinocourt et al. Injury‐induced axonal sprouting in the hippocampus is initiated by activation of trkB receptors
Willaime-Morawek et al. IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2?
Reyes-Harde et al. Postsynaptic phospholipase C activity is required for the induction of homosynaptic long-term depression in rat hippocampus
Poulsen et al. Glutamate receptor antagonists and growth factors modulate dentate granule cell neurogenesis in organotypic, rat hippocampal slice cultures
Piscopo et al. Hypoxia induces up-regulation of progranulin in neuroblastoma cell lines
Wiera et al. Impact of matrix metalloproteinase-9 overexpression on synaptic excitatory transmission and its plasticity in rat CA3-CA1 hippocampal pathway
Tsukamoto et al. Upregulation of galectin-3 in immortalized Schwann cells IFRS1 under diabetic conditions
Haubold et al. Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells
Payne et al. Histamine inhibits conducted vasodilation through endothelium‐derived NO production in arterioles of mouse skeletal muscle